Thumbnail Image
Publication

Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.

Ultsch, Bernhard
; 
Weidemann, Felix
; 
Reinhold, Thomas
; 
Siedler, Anette
; ; 
Wichmann, Ole
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2013
Submitted date
Show all metadata
Files
Thumbnail Image
Open Access publication
Adobe PDF, 311.17 KB
Other Titles
Abstract
Herpes zoster (HZ) is a self-limiting painful skin rash affecting mostly individuals from 50 years of age. The main complication is postherpetic neuralgia (PHN), a long-lasting pain after rash has resolved. A HZ-vaccine has recently been licensed in Europe for individuals older than 50 years. To support an informed decision-making for a potential vaccination recommendation, we conducted a health economic evaluation to identify the most cost-effective vaccination strategy.
Citation
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. 2013, 13:359 BMC Health Serv Res
Affiliation
Helmholtz Centre for infection research, Inhoffenstr. 7, D-38124 Braunschweig, Germany.
Publisher
Journal
BMC health services research
URI
http://hdl.handle.net/10033/582736
DOI
10.1186/1472-6963-13-359
PubMed ID
24070414
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1472-6963
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Collections
publications of the research group of epidemiology (EPID)